{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:28Z","timestamp":1792788208062,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jdermsci.2023.04.006","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T13:13:53Z","timestamp":1682428433000},"page":"78-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Targeting the elevated IFN-\u03b3 in vitiligo patients by human anti- IFN-\u03b3 monoclonal antibody hampers direct cytotoxicity in melanocyte"],"prefix":"10.1016","volume":"110","author":[{"given":"Chau Yee","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Pei","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Chuan","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Po","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Ning","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Han","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Lung","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdermsci.2023.04.006_bib1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jaad.2016.12.021","article-title":"Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity","volume":"76","author":"Strassner","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"610","key":"10.1016\/j.jdermsci.2023.04.006_bib2","doi-asserted-by":"crossref","first-page":"eabd8995","DOI":"10.1126\/scitranslmed.abd8995","article-title":"scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in Treg function","volume":"13","author":"Gellatly","year":"2021","journal-title":"Sci. Transl. Med"},{"issue":"7","key":"10.1016\/j.jdermsci.2023.04.006_bib3","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","article-title":"Model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8+ T-cell accumulation in the skin","volume":"132","author":"Harris","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2023.04.006_bib4","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"Boorn","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2023.04.006_bib5","doi-asserted-by":"crossref","first-page":"0","DOI":"10.2340\/00015555-2137","article-title":"IFN-\u03b3 in vitiligo, is it the fuel or the fire?","author":"Harris","year":"2014","journal-title":"Acta Derm. Venereol."},{"issue":"3","key":"10.1016\/j.jdermsci.2023.04.006_bib6","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2017.07.011","article-title":"Vitiligo: mechanistic insights lead to novel treatments","volume":"140","author":"Frisoli","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.jdermsci.2023.04.006_bib7","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41584-021-00694-z","article-title":"Targeting interferon-\u03b3 in hyperinflammation: opportunities and challenges","volume":"17","author":"De Benedetti","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jdermsci.2023.04.006_bib8","doi-asserted-by":"crossref","unstructured":"V.T. Natarajan, P. Ganju, A. Singh, V. Vijayan, K. Kirty, S. Yadav, et al., IFN-\u03b3 signaling maintains skin pigmentation homeostasis through regulation of melanosome maturation, Proceedings of the National Academy of Sciences 111(6) (2014) 2301\u20132306.","DOI":"10.1073\/pnas.1304988111"},{"issue":"3","key":"10.1016\/j.jdermsci.2023.04.006_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093232","article-title":"Interferon-gamma induces senescence in normal human melanocytes","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jdermsci.2023.04.006_bib10","first-page":"3111","article-title":"IFN\u2011\u03b3 induces apoptosis in human melanocytes by activating the JAK1\/STAT1 signaling pathway","volume":"22","author":"Su","year":"2020","journal-title":"Mol. Med Rep."},{"issue":"1","key":"10.1016\/j.jdermsci.2023.04.006_bib11","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jdermsci.2023.04.006_bib12","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo, Nature","volume":"10","author":"Tulic","year":"2019","journal-title":"Communications"},{"issue":"6","key":"10.1016\/j.jdermsci.2023.04.006_bib13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2340\/00015555-2080","article-title":"Interferon-gamma inhibits melanogenesis and induces apoptosis in melanocytes: a pivotal role of CD8+ cytotoxic T lymphocytes in vitiligo","volume":"95","author":"Yang","year":"2015","journal-title":"Acta Derm. Venereol."},{"issue":"2","key":"10.1016\/j.jdermsci.2023.04.006_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/pcmr.12955","article-title":"The fate of melanocyte: mechanisms of cell death in vitiligo","volume":"34","author":"Wu","year":"2021","journal-title":"Pigment Cell Melanoma Res."},{"issue":"1","key":"10.1016\/j.jdermsci.2023.04.006_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2015.09.003","article-title":"Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?","volume":"81","author":"Xie","year":"2016","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.jdermsci.2023.04.006_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.jdermsci.2023.04.006_bib17","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2133.2003.05303.x","article-title":"Oxidative stress in malignant melanoma and non-melanoma skin cancer","volume":"148","author":"Sander","year":"2003","journal-title":"Br. J. Dermatol."},{"issue":"7","key":"10.1016\/j.jdermsci.2023.04.006_bib18","first-page":"701","article-title":"Evaluation of total oxidant and antioxidant status in localized and generalized vitiligo","volume":"38","author":"Akoglu","year":"2013","journal-title":"Clin. Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.jdermsci.2023.04.006_bib19","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0300060513516294","article-title":"Role of oxidative stress in the pathogenesis of vitiligo with special emphasis on the antioxidant action of narrowband ultraviolet B phototherapy","volume":"42","author":"Karsli","year":"2014","journal-title":"J. Int. Med. Res."},{"issue":"4","key":"10.1016\/j.jdermsci.2023.04.006_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.autrev.2016.01.004","article-title":"The role of IL-17 in vitiligo: a review","volume":"15","author":"Singh","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.jdermsci.2023.04.006_bib21","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jid.2017.03.020","article-title":"CXCL12 as a predictor of vitiligo activity and disease progression","volume":"137","author":"Alexeev","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"7","key":"10.1016\/j.jdermsci.2023.04.006_bib22","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.jid.2017.02.012","article-title":"Geel, alterations of CXCL12 in serum of patients with vitiligo","volume":"137","author":"Speeckaert","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"10.1016\/j.jdermsci.2023.04.006_bib23","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1111\/jocd.13908","article-title":"Marie, Elevated serum level of interleukin-15 in vitiligo patients and its correlation with disease severity but not activity","volume":"20","author":"Atwa","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"issue":"9","key":"10.1016\/j.jdermsci.2023.04.006_bib24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.autrev.2017.07.005","article-title":"Biomarkers of disease activity in vitiligo: a systematic review","volume":"16","author":"Speeckaert","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"9","key":"10.1016\/j.jdermsci.2023.04.006_bib25","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/nm.4158","article-title":"Identification of a major epitope by anti-interferon-\u03b3 autoantibodies in patients with mycobacterial disease","volume":"22","author":"Lin","year":"2016","journal-title":"Nat. Med."},{"issue":"7238","key":"10.1016\/j.jdermsci.2023.04.006_bib26","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nature07930","article-title":"Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals","volume":"458","author":"Scheid","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2023.04.006_bib27","article-title":"Pathogenic autoantibodies to IFN-\u03b3 act through the impedance of receptor assembly and Fc-mediated response","author":"Han-Po Shih","year":"2022","journal-title":"J. Exp. Med. Revis."},{"issue":"1\u20132","key":"10.1016\/j.jdermsci.2023.04.006_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jim.2011.06.033","article-title":"Multiplex measurement of proinflammatory cytokines in human serum: comparison of the Meso Scale Discovery electrochemiluminescence assay and the Cytometric Bead Array","volume":"372","author":"Dabitao","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jdermsci.2023.04.006_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymeth.2018.10.018","article-title":"Quantitation of low abundant soluble biomarkers using high sensitivity Single Molecule Counting technology","volume":"158","author":"Hwang","year":"2019","journal-title":"Methods"},{"key":"10.1016\/j.jdermsci.2023.04.006_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.872458","article-title":"Skin interstitial fluid and plasma multiplex cytokine analysis reveal ifn\u03b3 signatures and granzyme B as useful biomarker for activity, severity and prognosis assessment in vitiligo.","author":"Ng","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jdermsci.2023.04.006_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"issue":"7755","key":"10.1016\/j.jdermsci.2023.04.006_bib32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"issue":"7755","key":"10.1016\/j.jdermsci.2023.04.006_bib33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"issue":"223","key":"10.1016\/j.jdermsci.2023.04.006_bib34","doi-asserted-by":"crossref","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci. Transl. Med"},{"issue":"2","key":"10.1016\/j.jdermsci.2023.04.006_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10616-012-9481-y","article-title":"Beyond annexin V: fluorescence response of cellular membranes to apoptosis","volume":"65","author":"Demchenko","year":"2013","journal-title":"Cytotechnology"},{"issue":"6","key":"10.1016\/j.jdermsci.2023.04.006_bib36","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/leu.2014.17","article-title":"Autopsy of a cell","volume":"28","author":"Bendall","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.jdermsci.2023.04.006_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00000372-200404000-00004","article-title":"Inflammatory changes in vitiligo: stage I and II depigmentation","volume":"26","author":"Sharquie","year":"2004","journal-title":"Am. J. Derm."},{"issue":"2","key":"10.1016\/j.jdermsci.2023.04.006_bib38","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/med.21754","article-title":"Mechanisms of melanocyte death in vitiligo","volume":"41","author":"Chen","year":"2021","journal-title":"Med Res Rev."},{"issue":"7","key":"10.1016\/j.jdermsci.2023.04.006_bib39","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1084\/jem.20181892","article-title":"Cell death-mediated cytokine release and its therapeutic implications","volume":"216","author":"Place","year":"2019","journal-title":"J. Exp. Med"},{"issue":"10244","key":"10.1016\/j.jdermsci.2023.04.006_bib40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0140-6736(20)30609-7","article-title":"Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial","volume":"396","author":"Rosmarin","year":"2020","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.jdermsci.2023.04.006_bib41","first-page":"22","article-title":"Interfering with the IFN-\u03b3\/CXCL10 pathway to develop new targeted treatments for vitiligo","volume":"3","author":"Rashighi","year":"2015","journal-title":"Ann. Transl. Med."},{"issue":"4","key":"10.1016\/j.jdermsci.2023.04.006_bib42","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","article-title":"JAK inhibitors in dermatology: the promise of a new drug class","volume":"76","author":"Damsky","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.jdermsci.2023.04.006_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/030097401316909530","article-title":"Randomized, double-blind trial of anti-interferon-gamma antibodies in rheumatoid arthritis","volume":"30","author":"Sigidin","year":"2001","journal-title":"Scand. J. Rheuma"},{"key":"10.1016\/j.jdermsci.2023.04.006_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-065X.2008.00698.x","article-title":"Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha\/beta, IFN-gamma, and IFN-lambda in host defense","volume":"226","author":"Zhang","year":"2008","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.jdermsci.2023.04.006_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/bloodadvances.2018025858","article-title":"Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections","volume":"3","author":"Lounder","year":"2019","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.jdermsci.2023.04.006_bib46","first-page":"52","article-title":"Anti-interferon-gamma antibodies in the treatment of autoimmune diseases","volume":"5","author":"Skurkovich","year":"2003","journal-title":"Curr. Opin. Mol. Ther."},{"issue":"1","key":"10.1016\/j.jdermsci.2023.04.006_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2017-000226","article-title":"Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-\u03b3 monoclonal antibody, in SLE subjects without or with lupus nephritis","volume":"4","author":"Boedigheimer","year":"2017","journal-title":"Lupus Sci. Med."},{"issue":"19","key":"10.1016\/j.jdermsci.2023.04.006_bib48","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in children with primary hemophagocytic lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"New Engl. J. Med."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181123001135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181123001135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:52:51Z","timestamp":1760331171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181123001135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0923181123001135"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2023.04.006","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the elevated IFN-\u03b3 in vitiligo patients by human anti- IFN-\u03b3 monoclonal antibody hampers direct cytotoxicity in melanocyte","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2023.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}